Ikarian Capital’s Seagen Inc. Common Stock SGEN Stock Holding History

Ikarian Capital’s Portfolio SGEN Stock Details SGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-25,000	Closed	-$3.21M	–	134
2022 Q4	$3.21M	Buy	+25,000	New	+$3.23M	0.78%	37

Other funds holding SGEN

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ikarian Capital's SGEN Position: Q1 2023 in Review

Ikarian Capital sold out of Seagen Inc. Common Stock (SGEN) in Q1 2023, closing a stake of 25,000 shares — an estimated $3.21M sold.

Ikarian Capital first reported a position in SGEN in Q4 2022 and held it in 1 quarter. The position peaked at $3.21M in Q4 2022. 575 funds tracked by Wall St. Rank hold SGEN as of Q1 2023.

Ikarian Capital reported no remaining Seagen Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Ikarian Capital sold 25,000 Seagen Inc. Common Stock shares in Q1 2023, an estimated $3.21M.
Ikarian Capital first reported a position in Seagen Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Ikarian Capital's Seagen Inc. Common Stock position peaked at $3.21M in Q4 2022.
575 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q1 2023.

Based on Ikarian Capital's 13F filing for Q1 2023, filed 15 May 2023.